Clinically, NIS-mediated radioiodide transport has been the centerpiece of diagnostic tests and ablative interventions in well-differentiated thyroid cancers for over 65 years [5, 25, 26]. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.